This case illustrates the importance of having experienced providers working together in a multidisciplinary pathway to address complex disease processes and develop an individualized treatment program for each patient.
A 37-year-old woman presented with recurring painful swelling and erythema of the vulva, negative vaginal cultures, and a 4 mm nodule on right labium minus. Read more about this extraintestinal manifestation of Crohn disease.
Cleveland Clinic’s enterprise-wide inflammatory bowel disease (IBD) program has entered a new era, combining novel medical and surgical therapies with pioneering research.
The inflammatory bowel disease patient-centered medical home is a new and novel collaborative approach to the problem of fragmented, ineffective and costly care. It pairs patients with a multispecialty team of healthcare providers who emphasize preventive care and nutrition and treat co-existing pain and psychological issues.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Clinicians increasingly are recognizing the need to recognize and manage inflammatory bowel disease’s extra-intestinal manifestations. A new Cleveland Clinic review provides guidance.
Learn how Cleveland Clinic is advancing gastrointestinal care: Examining the link between IBD and liver disease, predicting progression in Barrett’s esophagus and investigating stem cell therapy for Crohn’s disease.
The presence of inflammatory bowel disease conveys increased risk of comorbid nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and nonalcoholic cirrhosis, two new Cleveland Clinic epidemiological studies show.
Miguel Regueiro, MD, Chair of Cleveland Clinic’s Department of Gastroenterology, Hepatology and Nutrition, highlights six can’t-miss DDW presentations by our researchers.
If you’re looking for the latest insights and leading-edge information on IBD and gastrointestinal endoscopy, you’ll want to attend these upcoming Cleveland Clinic CME events.
Cleveland Clinic colorectal surgeon Amy Lightner, MD, a leading translational researcher and clinical trials director, talks about stem cells’ potential to improve IBD management.